These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 67817)

  • 1. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
    Schein PS; Winokur SH
    Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic drug-induced lung disease.
    Sostman HD; Matthay RA; Putman CE
    Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The action of antitumor agents: a double-edged sword?
    Sieber SM
    Med Pediatr Oncol; 1977; 3(2):123-31. PubMed ID: 327250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung damage from cytotoxic drugs.
    Collis CH
    Cancer Chemother Pharmacol; 1980; 4(1):17-27. PubMed ID: 6153937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of anticancer drugs during pregnancy.
    Stutzman L; Sokal JE
    Clin Obstet Gynecol; 1968 Jun; 11(2):416-27. PubMed ID: 4879373
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxic drug-induced pulmonary disease: update 1980.
    Weiss RB; Muggia FM
    Am J Med; 1980 Feb; 68(2):259-66. PubMed ID: 6153504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.
    Jaffe N
    Pediatr Clin North Am; 1976 Feb; 23(1):233-44. PubMed ID: 768885
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic and pancreatic damage produced by cytotoxic drugs.
    Woolley PV
    Cancer Treat Rev; 1983 Jun; 10(2):117-37. PubMed ID: 6223696
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of immunosuppressive drugs during pregnancy.
    Bermas BL; Hill JA
    Arthritis Rheum; 1995 Dec; 38(12):1722-32. PubMed ID: 8849343
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary toxicity of antineoplastic drugs.
    Willson JK
    Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fetal risk of cancer chemotherapy (author's transl)].
    Schaison G; Jacquillat C; Auclerc G; Weil M
    Bull Cancer; 1979; 66(2):165-70. PubMed ID: 465749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic tissue damage and immunosuppression].
    Holm O
    Lakartidningen; 1976 Apr; 73(17):1624-8. PubMed ID: 1083468
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hair changes in immunosuppressive therapy].
    Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J
    Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception].
    Marty M; Mignot L; Gisselbrecht G; Morvan F; Gorins A; Boiron M
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):181-6. PubMed ID: 12280202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of immunosuppressive drugs in man.
    Decker JL
    Arthritis Rheum; 1973; 16(1):89-91. PubMed ID: 4734960
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.
    Sieber SM; Adamson RH
    Adv Cancer Res; 1975; 22():57-155. PubMed ID: 766582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug side effects in antineoplastic and immunosuppressive cytostatic therapy].
    Hambsch K; Fischer H
    Z Gesamte Inn Med; 1984 Jan; 39(1):7-14. PubMed ID: 6711064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for preservation of ovarian and testicular function after immunosuppression.
    Pendse S; Ginsburg E; Singh AK
    Am J Kidney Dis; 2004 May; 43(5):772-81. PubMed ID: 15112167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bar-shaped nuclear bodies in oral epithelial cells of children receiving chemotherapy for cancer.
    Stern MH; Curtis AB
    Arch Oral Biol; 1971 Oct; 16(10):1241-3. PubMed ID: 5289683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.